5,6-Dichloro-1-beta-O-ribofuranosylbenzimidazole induces DNA damage by interfering with DNA topoisomerase II.
We have examined DNA in cells treated with 5,6-dichloro-1-beta-O-ribofuranosylbenzimidazole (DRB), an adenosine analogue. The results show that DRB induces an partial fragmentation of DNA when the cells are lysed in dilute alkali. Fragmentation of DNA does not occur in control cells, nor in cells pretreated with novobiocin or VP-16/VM-26. The data show that DRB interferes with DNA topoisomerase II. In agreement with this interpretation, crude nuclear extracts of DRB-treated cells result in reduced in vitro KC1/SDS precipitation of covalent protein-DNA complexes. Formation of covalent complexes is typical of topoisomerase-DNA interaction.
D016590:Aphidicolin; D002478:Cells, Cultured; D011232:Chemical Precipitation; D004247:DNA / Q000187:drug effects* / Q000302:isolation & purification; D004004:Dichlororibofuranosylbenzimidazole / Q000494:pharmacology*; D004224:Diterpenes / Q000494:pharmacology; D004587:Electrophoresis, Agar Gel; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D009675:Novobiocin / Q000494:pharmacology; D011506:Proteins / Q000302:isolation & purification; D012263:Ribonucleosides / Q000494:pharmacology*; D013713:Teniposide / Q000494:pharmacology; D059005:Topoisomerase II Inhibitors
D004224:Diterpenes; D011506:Proteins; D012263:Ribonucleosides; D059005:Topoisomerase II Inhibitors; D009675:Novobiocin; D016590:Aphidicolin; D004004:Dichlororibofuranosylbenzimidazole; D005047:Etoposide; D004247:DNA; D013713:Teniposide